Chapter 0: Introduction to the consensus on primary hyperparathyroidism from the French Society of Endocrinology, French speaking Association of Endocrine Surgery and French Society of Nuclear Medicine

IF 2.9 3区医学 Q3 ENDOCRINOLOGY & METABOLISM Annales d'endocrinologie Pub Date : 2025-02-01 DOI:10.1016/j.ando.2025.101689

Peter Kamenicky , Eric Mirallie , Elif Hindie , Marie-Christine Vantyghem , Laurent Brunaud

{"title":"Chapter 0: Introduction to the consensus on primary hyperparathyroidism from the French Society of Endocrinology, French speaking Association of Endocrine Surgery and French Society of Nuclear Medicine","authors":"Peter Kamenicky , Eric Mirallie , Elif Hindie , Marie-Christine Vantyghem , Laurent Brunaud","doi":"10.1016/j.ando.2025.101689","DOIUrl":null,"url":null,"abstract":"<div><div>This consensus on primary hyperparathyroidism, drawn up under the aegises of the French Society of Endocrinology (SFE), French speaking Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN), provides an update on positive, etiological and differential diagnosis and treatment in primary hyperparathyroidism. These recommendations take account of recent increase in the prevalence of primary hyperparathyroidism, due to 1. More systematic routine measurement of blood calcium and improved quality of parathyroid hormone assays, 2. Developments in genetics, 3. The steady increase in life expectancy, affecting the long-term consequences of asymptomatic hyperparathyroidism, 4. Advances in parathyroid imaging, 5. Targeted surgical management, 6. Therapeutic alternatives when surgery is contraindicated, and 7. Better understanding of pathophysiological mechanisms and hence of differential diagnoses, and in particular secondary and tertiary hyperparathyroidism. The consensus is published in French on the Société Française d’Endocrinologie website (<span><span>https://www.sfendocrino.org/</span><svg><path></path></svg></span>), and in English in the <em>Annales d’Endocrinologie</em>/<em>Annals of Endocrinology</em> and the <em>Journal of Visceral Surgery</em>. A summary for general practitioners will be made available on the French Health Authority (HAS) website (<span><span>https://www.has-sante.fr/</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":7917,"journal":{"name":"Annales d'endocrinologie","volume":"86 1","pages":"Article 101689"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales d'endocrinologie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003426625000083","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

This consensus on primary hyperparathyroidism, drawn up under the aegises of the French Society of Endocrinology (SFE), French speaking Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN), provides an update on positive, etiological and differential diagnosis and treatment in primary hyperparathyroidism. These recommendations take account of recent increase in the prevalence of primary hyperparathyroidism, due to 1. More systematic routine measurement of blood calcium and improved quality of parathyroid hormone assays, 2. Developments in genetics, 3. The steady increase in life expectancy, affecting the long-term consequences of asymptomatic hyperparathyroidism, 4. Advances in parathyroid imaging, 5. Targeted surgical management, 6. Therapeutic alternatives when surgery is contraindicated, and 7. Better understanding of pathophysiological mechanisms and hence of differential diagnoses, and in particular secondary and tertiary hyperparathyroidism. The consensus is published in French on the Société Française d’Endocrinologie website (https://www.sfendocrino.org/), and in English in the Annales d’Endocrinologie/Annals of Endocrinology and the Journal of Visceral Surgery. A summary for general practitioners will be made available on the French Health Authority (HAS) website (https://www.has-sante.fr/).

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

第0章：介绍了法国内分泌学会、法国内分泌外科学会和法国核医学学会对原发性甲状旁腺功能亢进的共识。

在法国内分泌学会（SFE）、法国内分泌外科学会（AFCE）和法国核医学学会（SFMN）的支持下，这份关于原发性甲状旁腺功能亢进的共识提供了原发性甲状旁腺功能亢进的阳性、病因和鉴别诊断和治疗的最新信息。这些建议考虑到最近原发性甲状旁腺功能亢进患病率的增加，原因是1。更系统的血钙常规测量和甲状旁腺激素检测质量的提高，2。3.遗传学的发展；预期寿命的稳步增加，影响无症状甲状旁腺功能亢进的长期后果。5.甲状旁腺影像学进展；6.针对性手术治疗；7.手术禁忌时的治疗选择；更好地了解病理生理机制，从而鉴别诊断，特别是继发性和三期甲状旁腺功能亢进。这一共识以法文发表在societ franaise d'Endocrinologie网站（https://www.sfendocrino.org）上，英文发表在《内分泌年鉴/内分泌年鉴》和《内脏外科杂志》上。针对全科医生的摘要将在法国卫生局（HAS）网站（https://www.has-sante.fr）上发布。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Annales d'endocrinologie 医学-内分泌学与代谢

CiteScore

4.40

自引率

6.50%

发文量

311

审稿时长

50 days

期刊介绍： The Annales d''Endocrinologie, mouthpiece of the French Society of Endocrinology (SFE), publishes reviews, articles and case reports coming from clinical, therapeutic and fundamental research in endocrinology and metabolic diseases. Every year, it carries a position paper by a work-group of French-language endocrinologists, on an endocrine pathology chosen by the Society''s Scientific Committee. The journal is also the organ of the Society''s annual Congress, publishing a summary of the symposia, presentations and posters. "Les Must de l''Endocrinologie" is a special booklet brought out for the Congress, with summary articles that are always very well received. And finally, we publish the high-level instructional courses delivered during the Henri-Pierre Klotz International Endocrinology Days. The Annales is a window on the world, keeping alert clinicians up to date on what is going on in diagnosis and treatment in all the areas of our specialty.